Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katelyn V. Smith"'
Autor:
Alexander J Blood, Thomas A. Gaziano, Liliana E. Fera, Katelyn V. Smith, Jacqueline R. Dunning, Kavishwar B. Wagholikar, Benjamin M. Scirica, Shawn N. Murphy, Ana A. Mercurio-Pinto, Lina Matta, Samuel J. Aronson, Joshua W. Bosque-Hamilton, Christina M. Fischer, Akshay S. Desai, Taylor E. MacLean, Calum A. MacRae
Publikováno v:
Clinical Cardiology
Although optimal pharmacological therapy for heart failure with reduced ejection fraction (HFrEF) is carefully scripted by treatment guidelines, many eligible patients are not treated with guideline‐directed medical therapy (GDMT) in clinical pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83793539cd69ab3c570657716ccc8975
https://doi.org/10.1002/clc.23291
https://doi.org/10.1002/clc.23291
Autor:
Benjamin M. Scirica, Layne Ainsworth, Thomas A. Gaziano, Eloy Toscano, Shawn N. Murphy, Christina M. Fischer, Brent Richter, Kavishwar B. Wagholikar, Taylor E. MacLean, Calum A. MacRae, Liliana E. Fera, Joshua W. Bosque-Hamilton, Samuel J. Aronson, Jacqueline R. Dunning, Michael Oates, Akshay S. Desai, Katelyn V. Smith, Alyssa P. Goodson, Christopher Herrick, Lina Matta
Publikováno v:
Journal of Clinical Medicine Research
Background: The conventional approach for clinical studies is to identify a cohort of potentially eligible patients and then screen for enrollment. In an effort to reduce the cost and manual effort involved in the screening process, several studies h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d91a9bf6a4e7b91d58bd54e8fbdad77
https://doi.org/10.14740/jocmr3830
https://doi.org/10.14740/jocmr3830
Autor:
Jacqueline R. Dunning, Joshua W. Bosque-Hamilton, Liliana E. Fera, David Zelle, Katelyn V. Smith, Taylor E. MacLean, Calum A. MacRae, Jamaal Y Grant, Christina M. Fischer, Benjamin M. Scirica, Thomas A. Gaziano, Lina Matta, Akshay S. Desai
Publikováno v:
Journal of pharmacy practice. 35(5)
Background: Although strategies for optimization of pharmacologic therapy in patients with heart failure with reduced ejection fraction (HFrEF) are scripted by guidelines, data from HF registries suggests that guideline-directed medical therapies (GD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a432c70d5c9920d47605e7b36b89b91
https://pubmed.ncbi.nlm.nih.gov/33813934
https://pubmed.ncbi.nlm.nih.gov/33813934
Autor:
Christina M. Fischer, Lina Matta, Benjamin M. Scirica, Liliana E. Fera, Thomas A. Gaziano, Jacqueline R. Dunning, Taylor E. MacLean, Calum A. MacRae, Katelyn V. Smith, Akshay S. Desai, Joshua W. Bosque-Hamilton
Publikováno v:
Journal of Cardiac Failure. 24:S100-S101
Introduction Although strategies for optimization of pharmacologic therapy in patients with heart failure with reduced ejection fraction (HFrEF) are carefully scripted by guidelines, data from large HF registries suggests that guideline-directed medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a6c9c075fff2046394f9c57e23caba6
https://doi.org/10.1016/j.cardfail.2018.07.382
https://doi.org/10.1016/j.cardfail.2018.07.382
Autor:
Shawn N. Murphy, Kavishwar Wagolikar, Lina Matta, Liliana E. Fera, Jacqueline R. Dunning, Christina M. Fischer, Samuel J. Aronson, Thomas A. Gaziano, Taylor E. MacLean, Calum A. MacRae, Joshua W. Bosque-Hamilton, Katelyn V. Smith, Benjamin M. Scirica, Ana A. Mercurio-Pinto, Akshay S. Desai
Publikováno v:
Journal of Cardiac Failure. 24:S99
Introduction Although optimal pharmacological therapy for heart failure with reduced ejection fraction (HFrEF) is carefully scripted by treatment guidelines, many eligible patients are not treated with guideline-directed medical therapy (GDMT) in cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05b396f9c17ef661c2c4c110ed78004f
https://doi.org/10.1016/j.cardfail.2018.07.379
https://doi.org/10.1016/j.cardfail.2018.07.379